NS
TVTX icon

NBC Securities’s Travere Therapeutics TVTX Stock Holding History

NBC Securities’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Buy
+3,853
New +$171K 0.01% 821
2025
Q4 		– Sell
-647
Closed -$15.5K – 2929
2025
Q3 		$15.5K Buy
647
+168
+35% +$3.16K ﹤0.01% 1866
2025
Q2 		$7K Hold
479
– – ﹤0.01% 2049
2025
Q1 		$8K Buy
+479
New +$9.72K ﹤0.01% 1791
2024
Q4 		– Sell
-479
Closed -$6K – 2020
2024
Q3 		$6K Hold
479
– – ﹤0.01% 1860
2024
Q2 		$3K Hold
479
– – ﹤0.01% 1956
2024
Q1 		$3K Hold
479
– – ﹤0.01% 1965
2023
Q4 		$4K Hold
479
– – ﹤0.01% 1926
2023
Q3 		$4K Buy
+479
New +$6.76K ﹤0.01% 1924

Other funds holding TVTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

NBC Securities's TVTX Position: Q2 2026 in Review

NBC Securities opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 3,853 shares worth $219K. The stake represents 0.01% of the portfolio and ranks #821 among its holdings. This is a return to the name: NBC Securities previously reported a position in TVTX as recently as Q3 2025.

NBC Securities first reported a position in TVTX in Q3 2023 and has held it in 9 quarters since. 26 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • NBC Securities held 3,853 shares of Travere Therapeutics worth $219K as of Q2 2026.
  • Travere Therapeutics was a new NBC Securities position in Q2 2026.
  • Travere Therapeutics made up 0.01% of NBC Securities's portfolio in Q2 2026, its #821 holding.
  • NBC Securities first reported a position in Travere Therapeutics in Q3 2023 and has held it in 9 quarters since.
  • 26 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.